
Iprazest PD 1.25mcg/500mcg Respules
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Levosalbutamol (1.25mcg) + Ipratropium (500mcg)
Overview Iprazest PD 1.25mcg/500mcg Respules
Iprazest PD 1.25mcg/500mcg inhalation solution treats chronic obstructive pulmonary disease (COPD), a lung condition hindering airflow. It eases breathing by relaxing airway muscles, alleviating coughing, wheezing, and breathlessness. Your physician will determine the appropriate inhalation frequency. While effects may appear within days, maximum benefit takes several weeks. Consistent use is crucial for efficacy; continue even without symptoms – this indicates effectiveness. Discontinuation may worsen COPD. This medication isn't for sudden breathlessness; use your rescue inhaler instead. Proper inhaler technique is essential for optimal results. Common side effects include dry mouth, breathlessness, cough, tremors, headache, palpitations, and muscle cramps. If experienced, consult your doctor, but don't stop treatment. Rinsing your mouth or brushing teeth after inhalation can mitigate some side effects. Less frequent, but potentially serious side effects exist; discuss concerns with your doctor. Inform your doctor of any kidney or liver conditions, or pregnancy/breastfeeding plans, to ensure appropriate dosage.
Primary Ingredients of Iprazest PD 1.25mcg/500mcg Respules
No information provided. Please provide the text you wish to be rephrased.
Uses of Iprazest PD 1.25mcg/500mcg Respules
Managing chronic obstructive pulmonary disease (COPD), asthma, and bronchitis through therapeutic intervention and preventative measures.
Major Benefits of Iprazest PD 1.25mcg/500mcg Respules:
Administer this medication precisely as your physician prescribes, adhering to both dosage and treatment duration. Consult the product label for complete instructions prior to use. Remove the respule/transpule cap and fully empty the contents into the nebulizer for immediate inhalation.
Common Side effects of Iprazest PD 1.25mcg/500mcg Respules:
- Dryness in mouth
- Cough
- Tremors
- Headache
- Palpitations
- Muscle cramp
- Back pain
- Chest pain
- Fatigue
- Dizziness
- Nausea
- Diarrhea
- Abdominal pain
- Vomiting
- Constipation
- Taste change
- Sore throat
How to use Iprazest PD 1.25mcg/500mcg Respules:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Always consult the product label for application instructions prior to use. Open the respule/transpule by twisting off the cap and completely transfer the contents into the nebulizer for immediate use.
How Iprazest PD 1.25mcg/500mcg Respules works:
Iprazest PD Respules (1.25 mcg levosalbutamol/500 mcg ipratropium) combine a bronchodilator, levosalbutamol, with the anticholinergic ipratropium. This dual action relaxes airway muscles, widening the passages for improved breathing.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Iprazest PD 1.25mcg/500mcg Respules and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Iprazest PD 1.25mcg/500mcg Respules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The inhalation of Iprazest PD 1.25mcg/500mcg Respules during breastfeeding appears to pose minimal risk to the infant, based on the currently available, albeit restricted, clinical data in humans.
DrivingNone
No known drug interactions.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Iprazest PD 1.25mcg/500mcg Respules :
Should you forget a dose of Iprazest PD 1.25mcg/500mcg Respules, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Iprazest PD 1.25mcg/500mcg Respules
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Breathing |
